AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GEIGER COUNTER LIMITED

Share Issue/Capital Change Jun 4, 2024

7665_rns_2024-06-04_4ba0e362-6a34-4e9a-b91a-1ae7dd8ea869.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0465R

Geiger Counter Ltd

04 June 2024

4 June 2024

GEIGER COUNTER LIMITED

(THE "COMPANY")

Exercise of outstanding Subscription Share Rights & Distribution of Rump proceeds

Further to the announcement on 9 May 2024 with regards to the exercise of the outstanding Subscription Rights (the "Rump") and the placing of the ordinary shares of no par value ("Ordinary Shares") that arose from the exercise of the Rump, the Company announces that proceeds of this placing, net of costs (the "Net Proceeds"), will be returned to those shareholders who did not exercise their rights ("Non-Subscribing Shareholders") by the Subscription Trustee as per the terms of the Subscription Rights.

In calculating the Net Proceeds to be returned to Non-Subscribing Shareholders, Subscription Rights entitlements were scaled back to approximately 70.96 per cent of the entitlement and multiplied by a rump payment rate of 13.0784844459919 pence per entitlement. Only Net Proceeds payments of £5 or more shall be made to Non-Subscribing Shareholders, with payments expected to take place on or around 5 June 2024.

For further information, please contact:

Manulife | CQS Investment Management Craig Cleland T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited Tunga Chigovanyika / Will Talkington (Corporate Finance) T: +44 (0) 20 7397 1915
Daniel Balabanoff / Pauline Tribe (Sales) T: +44 (0) 20 7220 0500
R&H Fund Services (Jersey) Limited Jane De Barros T :+44 (0) 1534 825 259

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEGCGDLCDGDGSS

Talk to a Data Expert

Have a question? We'll get back to you promptly.